{{Rsnum
|rsid=1478912
|Gene=RYR2
|Chromosome=1
|position=237457939
|Orientation=plus
|GMAF=0.4045
|Gene_s=RYR2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.0 | 42.5 | 26.5
| HCB | 57.7 | 36.5 | 5.8
| JPT | 67.3 | 31.0 | 1.8
| YRI | 33.3 | 44.2 | 22.4
| ASW | 17.5 | 50.9 | 31.6
| CHB | 57.7 | 36.5 | 5.8
| CHD | 59.6 | 33.9 | 6.4
| GIH | 49.5 | 35.6 | 14.9
| LWK | 12.8 | 54.1 | 33.0
| MEX | 41.4 | 46.6 | 12.1
| MKK | 12.2 | 47.4 | 40.4
| TSI | 29.4 | 51.0 | 19.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (docetaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=6E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}